Vancouver, Canada

Kathryn Westendorf

USPTO Granted Patents = 3 

Average Co-Inventor Count = 24.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kathryn Westendorf: Innovator in Anti-Coronavirus Antibodies

Introduction

Kathryn Westendorf is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies aimed at combating coronavirus-related diseases. With a total of 3 patents to her name, her work is pivotal in the ongoing fight against COVID-19.

Latest Patents

Westendorf's latest patents focus on anti-coronavirus antibodies and methods of use. These antibodies are designed to bind to the spike proteins of SARS-CoV and SARS-CoV-2. The methods outlined in her patents are intended for treating or preventing conditions associated with SARS or COVID-19, as well as for detecting these viruses. Her innovative approach has the potential to significantly impact public health.

Career Highlights

Throughout her career, Westendorf has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Abcellera Biologics Inc. Her experience in these institutions has equipped her with the knowledge and skills necessary to advance her research and inventions.

Collaborations

Westendorf has collaborated with talented individuals in her field, including Stefanie Zentelis and Krithika Muthuraman. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in biotechnology.

Conclusion

Kathryn Westendorf's contributions to the field of anti-coronavirus antibodies exemplify her dedication to innovation and public health. Her patents and collaborations reflect her commitment to advancing scientific knowledge and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…